Rostock, Germany
Cytocentrics, a 2001 founded biotechnology enterprise headquartered in Germany, specializes in automated patch clamp solutions tailored for the pharmaceutical sector. Their technology streamlines the patch clamp process, significantly reducing both time and costs for clients.
The company is renowned for its comprehensive consultancy service, optimizing systems and assays in ion channel research. Cytocentrics also extends its expertise by offering outsourced research and screening services from its German labs, catering to customers seeking convenience and proficiency.
Beyond pharmaceuticals, Cytocentrics has considerable experience in developing wafer-based thin film microsystems, with applications in microfluidics, pressure control, and micro-filtration. These capabilities serve labs across life sciences, diagnostics, and even food industries.
The company last attracted substantial investment in 2016, securing a $15.80M late venture capital round led by KfW and Stars Innovation. As a potentially lucrative investment, they continue to leverage their ion channel expertise within expansive markets.
